Biology subjects

Lefrancois, J.

Publications and source records attributed to Lefrancois, J..

3 recordsLinked to original sources

bioRxiv2026

Uncovering novel phage defense systems through genomic island analysis in Streptococcus thermophilus

Bacteria encode diverse antiviral defense systems, yet the evolutionary reservoirs that generate this immune innovation remain poorly defined. Although genomic context has been instrumental in discovering defense systems, genomic islands (GIs), variable chromosomal regions enriched in defense genes and proteins of unknown function, have not been systematically explored as sources of new bacterial immunity. Here, using comparative genomics of Streptococcus thermophilus, we identified 30 defense-associated GIs displaying extensive accessory gene diversity. Investigation of candidate loci from three GIs uncovered 15 previously uncharacterized antiviral systems, including 10 with novel architectures or features, revealing the potential within even a small subset of GIs. Several systems were not located near known defense genes, highlighting that GI-based discovery complements the traditional guilt-by-association approach, revealing systems that would otherwise remain undetected. Together, our findings establish GIs as reservoirs of antiviral innovation and provide a framework for uncovering the diversity of bacterial immune systems.

microbiology↗

bioRxiv2024

Strengthening Phage Resistance of Streptococcus thermophilus by Leveraging Complementary Defense Systems

CRISPR-Cas and restriction-modification systems represent the core defense arsenal in Streptococcus thermophilus to block lytic phages, but their effectiveness is compromised by phages encoding anti-CRISPR proteins (ACRs) and other counter-defense strategies. Here, we explored the resistome of 263 S. thermophilus strains to uncover other anti-phage systems. The defense landscape of S. thermophilus was enriched by 21 accessory defense systems, 13 of which had not been previously investigated in this species. Experimental validation of 17 systems with 14 phages showed varying anti-phage levels, uncovering intra-genus specificities among the five viral genera infecting S. thermophilus. Interestingly, the resistance levels were even higher when some defense systems (Dodola and PD-Lambda-1) were expressed from a low-copy plasmid or when integrated into the chromosome. We also observed a synergistic effect when combining Gabija with CRISPR-Cas, underscoring the potential of these additional defense systems for developing more robust industrial S. thermophilus strains, particularly against ACR-encoding phages.

microbiology↗

bioRxiv2018

A human cell model of cardiac pathophysiological valvulogenesis

Genetically modified mice have advanced our understanding of valve development and related pathologies. Yet, little is known regarding human valvulogenesis in health and diseases. Genuine human in vitro models that reproduce valvular (patho)biology are thus needed. We here developed a human pluripotent stem cell-derived model fit to decode the early steps of human valvulogenesis and to recapitulate valve disease traits in a dish.\n\nUsing cellular based, single cell omics-informed and in vivo-validated approaches, we derived a population of pre-valvular endocardial cells from a pluripotent stem cell source. These human prevalvular cells (HPVCs) expressed gene patterns conforming to the atrio-ventricular canal (AVC) endocardium signature originally established in E9.0 mouse embryos. In fact, HPVC treated with BMP2, cultured onto mouse AVC cushions, or transplanted into the AVC of embryonic mouse hearts, underwent endothelial-to-mesenchymal transition and expressed markers of valve interstitial cells of different valvular layers demonstrating tissue functionality. HPVCs also differentiated into tendinous/chondrogenic cells in line with the valvular repertoire. Extending this valvulogenic model to patient specific iPS cells, we recapitulated features of mitral valve prolapse and uncovered that dysregulation of the SHH pathway is likely to be at the origin of the disease thus providing a putative therapeutic target.\n\nHuman pluripotent stem cells recapitulate early valvulogenesis and provide a powerful model to systematically decipher the origin and lineage contribution of different valvular cell types in humans as well as to study valve diseases in a dish.

developmental biology↗